Iron deficiency is one of the most common micronutrient deficiencies in the world in pregnant women and children and it causes increased risk of perinatal mortality, morbidity and developmental delay. Recent evidence has suggested that iron deficiency may protect against malaria. Thus, the wisdom of universal supplementation in areas of the world where malaria is endemic has come under scrutiny. This application will attempt to identify the mechanism by which the human host's iron status affects the P. falciparum parasite in vitro. Specifically, we will determine if the growth, maturation and invasion rate of P. falciparum parasites is reduced in red blood cells and/or serum from severely iron deficient individuals before and after iron supplementation. The results will contribute to efforts to develop evidence-based iron supplementation policies in malaria-endemic areas.

Public Health Relevance

Iron deficiency affects over 500 million people including many pregnant women and children from areas of the world that are plagued by malaria. It has been suggested that iron deficiency protects against malaria and questions have been raised about the risks associated with the universal iron supplementation programs in countries where malaria is endemic. In the proposed project, we will determine whether the growth and development of the malaria parasite is impacted by the host iron status in vitro. We will use RBC and sera from patients with severe iron deficiency anemia to look at this question in a very systematic way. This study will provide information for or against a possible mechanism by which iron deficiency may affect the malaria parasite. Ultimately, this information will provide additional evidence for the determination of policy on iron supplementation in malaria endemic regions.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HD061235-02S1
Application #
8326906
Study Section
Special Emphasis Panel (ZHD1-DSR-A (IM))
Program Officer
Raiten, Daniel J
Project Start
2009-08-20
Project End
2013-07-31
Budget Start
2010-08-01
Budget End
2013-07-31
Support Year
2
Fiscal Year
2011
Total Cost
$194,960
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Goheen, Morgan M; Campino, Susana; Cerami, Carla (2017) The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations. Br J Haematol 179:543-556
Goheen, M M; Wegmüller, R; Bah, A et al. (2016) Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron Supplementation. EBioMedicine 14:123-130
Goheen, Morgan M; Clark, Martha A; Kasthuri, Raj S et al. (2016) Biopreservation of RBCs for in vitro Plasmodium falciparum culture. Br J Haematol 175:741-744
Clark, Martha A; Goheen, Morgan M; Fulford, Anthony et al. (2014) Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nat Commun 5:4446
Clark, Martha A; Goheen, Morgan M; Spidale, Nicholas A et al. (2014) RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion. PLoS One 9:e101041
Clark, Martha; Fisher, Nancy C; Kasthuri, Raj et al. (2013) Parasite maturation and host serum iron influence the labile iron pool of erythrocyte stage Plasmodium falciparum. Br J Haematol 161:262-9
Prentice, Andrew M; Verhoef, Hans; Cerami, Carla (2013) Iron fortification and malaria risk in children. JAMA 310:914-5
Taylor, Steve M; Cerami, Carla; Fairhurst, Rick M (2013) Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathog 9:e1003327
Ferrer, Patricia; Tripathi, Abhai K; Clark, Martha A et al. (2012) Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model. PLoS One 7:e37171